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Abstract
Prevalence of end-stage renal disease (ESRD) in the US increased by 74% from 2000 to 2013. To investigate
the role of the broader environment on ESRD survival time, we evaluated average distance to the nearest
hospital by county (as a surrogate for access to healthcare) and the Environmental Quality Index (EQI), an
aggregate measure of ambient environmental quality composed of five domains (air, water, land, built, and
sociodemographic), at the county level across the US. Associations between average hospital distance, EQI,
and survival time for 1,092,281 people diagnosed with ESRD between 2000 and 2013 (age 18+, without
changes in county residence) from the US Renal Data System were evaluated using proportional-hazards
models adjusting for gender, race, age at first ESRD service date, BMI, alcohol and tobacco use, and rurality.
The models compared the average distance to the nearest hospital (20 miles) and overall EQI percentiles
[0-5), [5-20), [20-40), [40-60), [60-80), [80-95), and [95-100], where lower percentiles are interpreted as
better EQI. In the full, non-stratified model with both distance and EQI, there was increased survival for
patients over 20 miles from a hospital compared to those under 10 miles from a hospital (hazard ratio = 1.14,
95% confidence interval = 1.12-1.15) and no consistent direction of association across EQI strata. In the full
model stratified by average hospital distance, under 10 miles from a hospital had increased survival in the
worst EQI strata (median survival 3.0 vs. 3.5 years for best vs. worst EQI, respectively), however for people
over 20 miles from a hospital, median survival was higher in the best (4.2 years) vs worst (3.4 years) EQI. This
association held across different rural/urban categories and age groups. These results demonstrate the
importance of considering multiple factors when studying ESRD survival and future efforts should consider
additional components of the broader environment.
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Abstract
Prevalence of end-stage renal disease (ESRD) in the US increased by 74% from 2000 to
2013. To investigate the role of the broader environment on ESRD survival time, we evalu-
ated average distance to the nearest hospital by county (as a surrogate for access to health-
care) and the Environmental Quality Index (EQI), an aggregate measure of ambient
environmental quality composed of five domains (air, water, land, built, and sociodemo-
graphic), at the county level across the US. Associations between average hospital dis-
tance, EQI, and survival time for 1,092,281 people diagnosed with ESRD between 2000 and
2013 (age 18+, without changes in county residence) from the US Renal Data System were
evaluated using proportional-hazards models adjusting for gender, race, age at first ESRD
service date, BMI, alcohol and tobacco use, and rurality. The models compared the average
distance to the nearest hospital (<10, 10–20, >20 miles) and overall EQI percentiles [0–5),
[5–20), [20–40), [40–60), [60–80), [80–95), and [95–100], where lower percentiles are inter-
preted as better EQI. In the full, non-stratified model with both distance and EQI, there was
increased survival for patients over 20 miles from a hospital compared to those under 10
miles from a hospital (hazard ratio = 1.14, 95% confidence interval = 1.12–1.15) and no con-
sistent direction of association across EQI strata. In the full model stratified by average hos-
pital distance, under 10 miles from a hospital had increased survival in the worst EQI strata
(median survival 3.0 vs. 3.5 years for best vs. worst EQI, respectively), however for people
over 20 miles from a hospital, median survival was higher in the best (4.2 years) vs worst
(3.4 years) EQI. This association held across different rural/urban categories and age
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Introduction
The prevalence of end-stage renal disease (ESRD) in the United States (US) increased from
1,095 to 1,748 prevalent cases per million between the years of 2000 and 2013 with a five-year
survival of 42% for patients on hemodialysis [1]. In the US, ESRD disproportionately affects
racial and ethnic minorities with socioeconomic and environmental factors suspected to play a
role [2–5]. Similar disparities can also be found with patient access to and quality of care with
numerous studies reporting inequalities in nephrology services for socially disadvantaged
adults [2,3,5–8]. Further, impacts of geographic variability in access to care for kidney disease
survival are well documented. Greater risks for mortality have been observed with increasing
distance between patient residences and nephrologists [9–12] with the added variability of
quality of nephrology services offered further influencing survival [13,14]. While these studies
have assessed influences on patient survival time relative to distance from kidney care, this
does not address the influence of access to care for earlier health issues that may progress to
ESRD. Early detection of ESRD is expected to delay adverse outcomes [15–17] so assessing
patient survival based on distances to facilities utilized after diagnosis may not capture the full
influence of patient access to care on ESRD survival time.
Multiple studies have shown hospital utilization to be related to patient distance [18–20],
but associations between access to care and survival are varied depending on the outcome
under study [21–24]. In a review of 108 studies analyzing the association between travel time/
distance to health care and adverse patient outcomes, Kelly et al. found evidence of a positive
association in 77% of articles with others showing no association or an inverse association
[23]. In studies evaluating the role of hospital distance on survival, the focus tends to be on the
need for rapid emergency services [21,22,24] or on distance traveled following the diagnosis of
a disease [25–27] rather than the impact that distance could have for all health care needs lead-
ing to disease development. By studying more general health facilities such as hospitals for
patients who have lived in one geographic region their whole life, the role that geographic
access to care (rather than utilization, per se) plays in the pre- and post-diagnosis progression
and development of ESRD may be better captured. Further, because poorer socioeconomic
status is a risk factor for ESRD [2,28,29] and studies have shown increased hospital utilization
among these groups relative to those of higher socioeconomic status [18,30–32], hospitals may
be a good measure for access to care when analyzing associations with survival time for
patients with ESRD.
Geographic variability has been observed for both the incidence and prevalence of ESRD
with population-adjusted incidence rates from 2014 being highest in the Ohio Valley, Texas,
California, and the Southeast [1,2]. This geographic variability suggests some environmental
exposures may be determinants of ESRD, but the research on the impact of these factors is lim-
ited [2,33,34]. For instance, there is some evidence to support an association between pesticide
exposure and ESRD development [33,35], but concomitant exposures that could be contribut-
ing to ESRD have been understudied [36]. The sociodemographic environment is also sus-
pected to contribute to ESRD development, particularly due to the higher rates among racial
minorities and the socially disadvantaged [2,5,8]. Despite the apparent contributions from
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multiple environmental components influencing ESRD etiology, studies elucidating the role
that these aggregate exposures have on survival are limited.
The influence of environmental factors on any disease morbidity and mortality has been
shown to vary based on features of the physical environment. Still, studies are limited on the
effects of these multiple exposures in tandem and their correspondent health implications [37–
39]. The Environmental Quality Index (EQI) is an aggregate measure of ambient environmen-
tal quality and was constructed at the county-level across the US. It is composed of five
domains (air, water, land, built, and sociodemographic), each constructed to represent expo-
sures within that domain [40,41]. The EQI provides a means to relate the overall environment
to human health and has been used to investigate associations between environmental quality
and mortality rates in the US [39], cancer incidence rates [42], and infant mortality rates [43].
As a measure of environmental influence on disease progression and survival encompassing
different components of the environment, the EQI could offer insight into ESRD survival.
Factors contributing to patient survival from a disease are often encountered before the dis-
ease diagnosis, yet understanding of the role that the overall environment plays in this survival
is limited. Here we analyze patient data in the U.S. Renal Data System (USRDS) to evaluate
associations between survival in people living with ESRD following diagnosis and the broader
environment by analyzing access to care and the EQI. By analyzing the role that these two ele-
ments play in ESRD survival, we elucidate the potential impacts that the overall environment
has on ESRD survival and demonstrate the importance of analyzing multiple components of
the environment when studying complex diseases.
Materials and methods
Patients
The USRDS is the largest and most comprehensive national ESRD surveillance system in the
US [44]. The USRDS contains data on all ESRD cases in the US through the Medical Evidence
Report CMS-2728 which is mandated for all new patients diagnosed with ESRD [45]. Detailed
information about the USRDS can be found on their website (http://www.usrds.org).
We used the 2016 USRDS core patient, medical evidence, and residency Standard Analysis
Files for analysis in this study [46]. Data can be requested from USRDS. Written consent was
obtained from North Carolina State University Institutional Review Board for the use of
human subjects’ data. We identified 1,535,798 cases of ESRD diagnosed between January 2000
and December 2013 using the USRDS-derived first ESRD service date. Patients whose death
date was the same as their first ESRD service date were excluded (N = 6,064; 0.4%). We
excluded patients who were under 18 at their first ESRD service date (N = 14,034; 0.9%) as well
as those whose USRDS patient, medical evidence, and residency files were missing key study
covariates: race, gender, age, body mass index (BMI), current alcohol dependence, and current
tobacco use, or residency information (N = 46,990, 3.0%). This left us with 1,468,710 patients
for whom to determine average distance to the nearest hospital. Patients who had any resi-
dency outside of the US were excluded (N = 26,442, 1.8%). Patients who did not have a zip
code or county matching any on record were excluded (N = 5,334; 0. 4%), along with those
who had a zip code that did not correspond to the same state as the county code (N = 2,189,
0. 2%). Because both the EQI and the hospital distance determinations were at the county
level, any patients with residency files from multiple counties were excluded from the study
(N = 342,464, 23.9%). The demographic makeup of the patients who moved between counties
was similar to those that remained in one county for the duration of their lives, however
median survival was greater by 3 months for patients who moved compared to those who did
not move. Our final dataset included 1,092,281 patients.
Access to healthcare, environmental quality, and end-stage renal disease survival time
PLOS ONE | https://doi.org/10.1371/journal.pone.0214094 March 21, 2019 3 / 17
Average county hospital distance determinations
Multiple studies have shown straight-line (Euclidean) distance and actual travel distance over
a road network to be highly correlated [47–53]. Additionally, because our study covers a 14
year timeframe, the road networks for any given year would vary. The U.S. Department of
Transportation Federal Highway Administration estimates an additional 6,500 miles of roads
were built each year between 1980 and 2008 with additional increases in lanes of traffic and
public road bridges [54]. For these reasons, we used average distance to a hospital as a measure
of access to care. The average distance to the nearest hospital within each county in the US was
determined using the straight-line projected distance using geographic information systems
(GIS) software package suite ArcGIS version 10.5.1 [55]. A list of addresses for all hospitals
registered with Medicare in the US (last updated January 2018) was downloaded from the
Medicare website [56]. 93% of these addresses included latitudes and longitudes. We used
Google Earth to determine the geographic locations of the hospitals without these coordinates,
and converted these locations to latitude-longitude coordinates within the GIS software. Using
this methodology, all but one of the 4,747 hospitals were used in our analysis. A 0.05 degree lat-
itude-longitude grid of points was overlaid across the US, and the distance to the nearest hos-
pital was determined for each of these roughly 1.2 million grid points. Using 2010 U.S. Census
county lines [57], we determined the county in which each of these grid points was located.
This analysis was performed separately for Alaska, Hawaii, and the continental U.S., employ-
ing 0.05 degree grids and Albers equal area conic projections specific to each of these three
locations.
The average distance to the nearest hospital within each county was taken as the mean of
the distances to the closest hospital for all of the grid points that fell within the county. This
methodology enabled the determination of the distance to the nearest hospital from many
places within a county, disregarding whether the hospital was in the same county or state as
the county in question. We conducted this analysis at the county level to match the geographic
level of analysis of the EQI. The county FIPS codes and corresponding average distance to the
nearest hospital from the GIS analysis were matched to the county FIPS codes corresponding
to the USRDS patient data. If a patient’s county FIPS code did not match a county FIPS code
from the GIS analysis, then the patient’s zip code was used to identify the county FIPS code in
the HUD-USPS Crosswalk Files [58]. In total, there were 3,111 counties in our study. Average
distance to the nearest hospital for patients was stratified into three groups: those living in a
county with an average distance of under 10 miles, between 10–20 miles, and over 20 miles to
the nearest hospital. These intervals were selected to cover patients with a hospital nearby
(under 10 miles away) and patients in a more remote location (hospital over 20 miles away).
These bins were in accordance with definitions of remote locations and percentiles used in
other studies developing intervals for distance to care [9,10,59].
Environmental Quality Index
The EQI was used as a measure of cumulative environmental quality for counties across the
US. The development of the EQI has been well described [40,41]. In brief, the EQI was con-
structed for 2000–2005 for all US counties and is composed of five domains (air, water, built,
land, and sociodemographic), each composed of variables to represent the environmental
quality of that domain. Domain-specific EQIs were developed using principal components
analysis (PCA) to reduce these variables within each domain while the overall, total EQI was
constructed from a second PCA from these individual domains [41]. To account for differ-
ences in environment across rural and urban counties, the overall and domain-specific EQIs
were stratified by rural urban continuum codes (RUCCs) [60]. RUCCs are assigned by the
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USDA and describe how metropolitan or rural an area is using nine-item categories and these
RUCCs were binned into four categories with RUCC1 being the most metropolitan urbanized
and RUCC4 being the most rural [41]. These RUCC-stratified EQIs were in addition to the
overall EQI. These EQI data were downloaded from the U.S. EPA [61]. Higher EQI values cor-
respond to “worse” environmental quality, in that the variables used to construct the EQI were
associated with adverse health outcomes or ecologic effects [41].
All patients were assigned an EQI using county FIPS codes. EQI values for the total, overall
EQI domain as well as the five individual domains were grouped into quantiles according to
the distribution of the overall EQI: 0-5th percentile, 5th-20th percentile, 20th-40th percentile,
40th-60th percentile, 60th-80th percentile, 80th-95th percentile, and 95th-100th percentile, with
lower percentiles corresponding to better EQI values. These quantiles were selected to capture
the extremes of the “best” and “worst” EQIs and demonstrate the wide variability in EQIs
across the US [41]. In addition to the overall EQI and the five domains, the four RUCC-strati-
fied overall EQIs were grouped into the same percentiles according to their individual
distributions.
Statistical analysis
Patients were followed from their first ESRD service date (diagnosis) until death, date of first
transplant, or the end of the study time (31 December 2013). The total period of observation
was 14.0 years. Cox proportional hazards models were used to calculate hazard ratios (HRs)
for risk of mortality from ESRD for hospital distance and EQI after adjustment for covariates;
years of survival following diagnosis was the timescale. Covariates included were: gender, race
(African American, Asian, Caucasian, Native American, or Other, as reported in the USRDS
patient file), mean BMI from follow-up visits after diagnosis (underweight (below 18.5), nor-
mal weight (between 18.5 and 24.9), overweight (between 25 and 29.9), or obese (30 or over)),
alcohol use after ESRD diagnosis (as reported in the USRDS medical evidence report), tobacco
use after ESRD diagnosis (as reported in the USRDS medical evidence report), county-level
RUCCs to account for differences in rurality (RUCC1-RUCC4, most urban to most rural),
and age at first ESRD service date (between 18 and 39, between 40 and 65, over 65 years). Sepa-
rate models were generated with additional adjustment for either average distance to the near-
est hospital (under 10 miles, between 10 and 20 miles, or over 20 miles) or the overall, total
EQI (0-5th percentile, 5th-20th percentile, 20th-40th percentile, 40th-60th percentile, 60th-80th
percentile, 80th-95th percentile, or 95th-100th percentile). The full model included all of the
covariates with average distance to the nearest hospital and the total EQI mutually adjusted.
This full model was then stratified by average distance to the nearest hospital, and the resultant
model was further stratified separately by age and rurality with EQI quantiles developed using
the RUCC-stratified total EQIs. Additional models were prepared for each of the five EQI
domains (air, water, land, built, and sociodemographic) individually, with mutual adjustment
for average distance to the nearest hospital, and with the model stratified by average distance
to the nearest hospital.
Adjusted survival curves were generated using the corrected group prognosis method
which generates survival curves for each combination of covariates in the data using the pro-
portional hazards coefficients and takes a weighted average of these curves proportional to the
number of individuals for each combination [62]. Median and 90th percentile survival times
were determined from these adjusted survival curves with significance determinations based
on the proportional hazards coefficients used to develop the curves; 90th percentiles are
defined as 90% of patients have reached time of death. Survival analysis was completed using
the R/survival package [63]. All analyses were done using R version 3.3.2 [64].
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Results
Patient characteristics
Patient demographics organized by distance to the nearest hospital are summarized in Table 1.
Of the 1,092,281 patients, 783,857 (72%) lived under 10 miles from a hospital while 55,460
(5.1%) lived over 20 miles from a hospital. Each hospital distance group was similar for all
demographics except Native American race and rurality. For Native Americans, 37% lived
over 20 miles from the nearest hospital compared to 1.5–6.2% for non-Native American races.
For patients living farther from a hospital, the majority live in more rural communities com-
pared to those who live closer to a hospital. The majority of patients with hospitals in the most
rural regions are between 10–20 miles away (59.3%). The best EQI percentiles correspond
more with rural regions while the worst EQIs overlap more with urban regions. Over 600,000
Table 1. Demographic characteristics of 1,092,281 ESRD patients from 2000 to 2013 stratified by distance to the nearest hospital.
USRDS patients (n = 1,092,281)
% total patients in each demographic % patients in each hospital group
Under 10mi 10-20mi Over 20mi
Gender
Male 55.8 55.8 55.6 57.1
Female 44.2 44.2 44.4 42.9
Race
Caucasian 65.8 62.6 72.5 79.9
African American 28.6 31.9 22.6 8.4
Asian 4.2 4.7 2.9 3.5
Native American 1.1 0.4 1.8 7.8
Other 0.4 0.4 0.2 0.3
Age at first ESRD service date
18–39 7.9 7.9 7.8 8.4
40–65 44.4 44.0 45.0 48.2
Over 65 47.7 48.1 47.2 43.4
BMI
Normal weight 32.3 32.6 31.3 32.1
Underweight 3.9 4.1 3.6 3.4
Overweight 28.5 28.3 28.9 29.9
Obese 35.3 35.1 36.1 34.6
Current alcohol dependence
No 98.4 98.4 98.4 98.3
Yes 1.6 1.6 1.6 1.7
Current tobacco use
No 94.1 94.2 93.8 94.7
Yes 5.9 5.8 6.2 5.3
Rurality
Most Urban 83.1 88.2 69.1 76.2
Urban 7.1 5.4 12.1 9.0
Rural 8.1 5.8 14.7 11.2
Most Rural 1.6 0.7 4.2 3.7
All patients lived in one county for the duration of their lifetime.
aHospital group defined as average distance to the nearest hospital.
https://doi.org/10.1371/journal.pone.0214094.t001
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patients (>50%) lived in the two strata corresponding to worst environmental quality (80-95th
percentile, 95th-100th percentile) with 100,000 patients (~10%) living in the three best EQI
strata (0-5th percentile, 5th-20th percentile, 20th-40th percentile).
Total population-based analyses
We developed two separate proportional-hazards models to elucidate the individual effects of
hospital distance and EQI on survival time. Covariates included in both models were gender,
race, BMI, alcohol use, tobacco use, rurality, and age. When we added average distance to the
nearest hospital into our model (Table 2), we found increased survival time for patients living
over 20 miles from the nearest hospital compared to under 10 miles (hazard ratio (HR) = 0.90,
95% confidence interval (CI) = 0.89–0.91). Separately, when we added EQI into our model
Table 2. Proportional hazard model results for ESRD survival by hospital distance and EQI (1,092,281 patients, 2000–2013).
Hospital Distance EQI
HR (95% CI)a HR (95% CI)
Hospital Distance Under 10 miles Ref -
10–20 miles 0.98 (0.97–0.98) -
Over 20 miles 0.90 (0.89–0.91) -
EQI Category EQI 0–5% (best) - Ref
EQI 5–20% - 1.09 (1.05–1.13)
EQI 20–40% - 1.11 (1.07–1.15)
EQI 40–60% - 1.11 (1.07–1.15)
EQI 60–80% - 1.11 (1.07–1.15)
EQI 80–95% - 1.08 (1.04–1.12)
EQI 95–100% (worst) - 1.01 (0.98–1.05)
Race Caucasian Ref Ref
African American 0.80 (0.80–0.81) 0.80 (0.80–0.81)
Asian 0.59 (0.58–0.59) 0.60 (0.59–0.61)
Native American 0.82 (0.80–0.84) 0.79 (0.77–0.81)
Other 1.24 (1.20–1.29) 1.25 (1.20–1.30)
Gender Male Ref Ref
Female 1.01 (1.01–1.02) 1.01 (1.01–1.02)
BMI Normal weight Ref Ref
Underweight 1.31 (1.29–1.32) 1.31 (1.29–1.32)
Overweight 0.85 (0.85–0.86) 0.85 (0.85–0.86)
Obese 0.82 (0.81–0.82) 0.82 (0.81–0.82)
Alcohol Dependence No Ref Ref
Yes 1.23 (1.20–1.25) 1.23 (1.21–1.25)
Tobacco Use No Ref Ref
Yes 1.11 (1.10–1.12) 1.11 (1.10–1.12)
Rurality Most Urban Ref Ref
Urban 1.08 (1.07–1.09) 1.04 (1.03–1.06)
Rural 1.09 (1.08–1.10) 1.04 (1.03–1.06)
Most Rural 1.14 (1.12–1.16) 1.10 (1.08–1.12)
Age at first ESRD service date 18–39 Ref Ref
40–65 2.05 (2.02–2.08) 2.05 (2.02–2.08)
Over 65 4.26 (4.20–4.32) 4.27 (4.21–4.33)
aHR (95% CI) = Hazard ratio (95% Confidence Interval).
https://doi.org/10.1371/journal.pone.0214094.t002
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(Table 2), we found no significant difference in survival in the worst EQI compared to the best
EQI (HR = 1.01, 95% CI = 0.98–1.05). Stratifying these separate models into rural versus
urban categories did not change these associations (not shown).
Our full model included distance from the nearest hospital and EQI mutually adjusted to
assess possible effects on survival time in patients diagnosed with ESRD. Two adjusted survival
curves were generated from the full model: one stratified by distance to the nearest hospital
(Fig 1a) and one stratified by total EQI (Fig 1b). Adding total EQI into the model did not affect
the inverse association between survival and distance to the nearest hospital (Over 20 miles
compared to under 10 miles HR = 0.88, 95% CI = 0.87–0.89). Adding hospital distance into
the model did not influence the associations between environmental quality and patient sur-
vival time as there was no substantial difference between the best and worst EQI strata (Fig
1b). Repeating this analysis with the five individual domains of the EQI instead of the overall
EQI did not clarify these associations. Just as with the total EQI, survival time was significantly
greater farther from the nearest hospital. The direction of association between the EQI and
individual domains was inconsistent with no significant difference between the best and worst
EQI percentiles for the air and built EQI domain and an improvement in survival in worse
EQI percentiles compared to the best EQI percentile for the water and land EQI domain.
While survival was decreased in the worst EQI percentiles compared to the best EQI percentile
for the sociodemographic domain, there was no uniformity to this association between the
remaining strata (data not shown).
Hospital-distance stratified analyses
To further analyze the role of the broader environment on ESRD survival, we ran the full
model with the total EQI stratified by hospital distance (Fig 2, Table 3- all medians/90th per-
centiles determined from corrected group prognosis method adjusted survival curves gener-
ated using these proportional hazard model coefficients). We saw a negative association
between patient survival and better EQIs for patients living under 10 miles from the nearest
hospital, and a positive association between patient survival and better EQIs for patients living
over 20 miles from the nearest hospital. For patients under 10 miles from the nearest hospital,
Fig 1. Adjusted survival curves for all patients developed using the full model mutually adjusted for average distance to the nearest hospital and
total EQI. (a) Quantiles were generated using distance from the nearest hospital, (b) Quantiles were generated using total EQI.
https://doi.org/10.1371/journal.pone.0214094.g001
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median survival was 2.97 years (90th percentile 12.69 years) in the best EQI compared to a
median of 3.53 years (90th percentile over 14 years, survival beyond 2000–2013 study time) in
the worst EQI. This association is flipped for patients living over 20 miles from the nearest hos-
pital: median survival was 4.18 years in the best EQI (90th percentile over 14 years, survival
beyond 2000–2013 study time), and 3.43 years in the worst EQI (90th percentile 12.77 years).
For patients living between 10 and 20 miles from the nearest hospital, we saw no uniform
direction of association between better EQIs and patient survival: median survival was 3.47
years in the best EQI (90th percentile 13.50 years) and 3.45 years in the worst EQI (90th percen-
tile 13.48 years).
When we ran overall models stratified by age, survival differed by age (not shown). When
we further stratified the hospital distance-stratified model by age, we found the same negative
association between better EQIs and survival for patients under 10 miles from a hospital (S1
Fig, S1 Table). The strongest association was for the under 40 age group where median survival
in the best EQI percentile was 6.30 years and increases to 13.21 years in the worst EQI percen-
tile. As we found in the overall hospital distance-stratified model, for patients over 20 miles
from a hospital there is a positive association between survival time and better EQIs (S1 Fig).
This association is greatest in the 40–65 age group with a median and 90th percentile survival
of 5.53 and over 14 years (survival beyond 2000–2013 study time) in the best EQI percentile
and 4.46 and 12.73 years in the worst EQI percentile.
In overall models stratified by rurality, we did not find differing survival (not shown).
Because both the environment and distance to the nearest hospital could be influenced by
rurality, we stratified the hospital distance-stratified model by rurality groups. The same gen-
eral pattern that we found for the overall hospital distance-stratified model and age and hospi-
tal distance-stratified model held across hospital distance and rural group-stratified models
(S2 Fig, S2 Table).
To determine if any of the individual EQI domains were contributing to the pattern we
found for the total EQI hospital distance-stratified model, we stratified each domain of the
EQI by the distance to the nearest hospital. While there was no substantial difference between
Fig 2. Bar graphs for patient median and 90th percentile survival for different total EQI domains from the full
model separated by average distance to the nearest hospital. Quantile 1 = best EQI, Quantile 7 = worst EQI.
Orange = Patients with nearest hospital under 10 miles away, Green = Patients with nearest hospital 10–20 miles away,
Blue = Patients with nearest hospital over 20 miles away. Hazard ratios (Table 3) were used with the corrected group
prognosis method to generate adjusted survival curves and generate medians/90th percentile survival.
https://doi.org/10.1371/journal.pone.0214094.g002
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the different hospital groups for the air, water, and land EQI domains (not shown), the built
and sociodemographic EQI domains had a pattern similar to the total EQI hospital distance-
stratified model (Table 4). For the sociodemographic domain, patients within 10 miles of the
nearest hospital had increased survival in the worst EQI percentile compared to the best per-
centile (HR = 0.96, 95% CI = 0.93–0.98) and patients over 20 miles from the nearest hospital
had decreased survival in the worst EQI percentile compared to the best percentile (HR = 1.17,
95% CI = 1.09–1.27). This same pattern also occurred in the built domain, but the results were
not significant.
Discussion
We found that survival time for patients with ESRD was higher among those residing farther
from the nearest hospital. This association held across different rural and urban continua.
Compared to living within ten miles of the nearest hospital, patients living over 20 miles away
Table 3. Hazard ratios for ESRD and total EQI stratified by distance to the nearest hospital (1,092,281 patients, 2000–2013).
Hospital Distance
Under 10 miles (N = 783,857) 10–20 miles (N = 252,964) Over 20 miles (N = 55,460)
HR (95% CI)a HR (95% CI) HR (95% CI)
EQI Category EQI 0–5% (best) Ref Ref Ref
EQI 5–20% 1.02 (0.92–1.12) 1.06 (1.01–1.11) 1.12 (1.03–1.23)
EQI 20–40% 0.98 (0.89–1.08) 1.11 (1.06–1.16) 1.06 (0.97–1.14)
EQI 40–60% 0.98 (0.89–1.09) 1.07 (1.03–1.12) 1.17 (1.08–1.27)
EQI 60–80% 0.95 (0.85–1.05) 1.12 (1.07–1.17) 1.15 (1.05–1.25)
EQI 80–95% 0.93 (0.84–1.03) 1.00 (0.96–1.05) 1.17 (1.07–1.27)
EQI 95–100% (worst) 0.85 (0.77–0.94) 1.00 (0.96–1.06) 1.22 (1.10–1.35)
Race Caucasian Ref Ref Ref
African American 0.78 (0.78–0.79) 0.82 (0.81–0.83) 0.86 (0.82–0.90)
Asian 0.58 (0.57–0.59) 0.63 (0.61–0.66) 0.66 (0.61–0.70)
Native American 0.92 (0.88–0.97) 0.83 (0.79–0.86) 0.74 (0.71–0.77)
Other 1.20 (1.16–1.25) 1.32 (1.19–1.45) 1.70 (1.44–2.01)
Gender Male Ref Ref Ref
Female 1.02 (1.01–1.02) 1.00 (0.99–1.02) 0.99 (0.97–1.02)
BMI Normal weight Ref Ref Ref
Underweight 1.30 (1.28–1.32) 1.32 (1.28–1.35) 1.33 (1.25–1.41)
Overweight 0.85 (0.84–0.86) 0.85 (0.84–0.86) 0.87 (0.84–0.89)
Obese 0.82 (0.81–0.82) 0.81 (0.80–0.82) 0.83 (0.81–0.85)
Alcohol Dependence No Ref Ref Ref
Yes 1.22 (1.19–1.25) 1.23 (1.18–1.28) 1.37 (1.25–1.49)
Tobacco Use No Ref Ref Ref
Yes 1.09 (1.08–1.11) 1.12 (1.09–1.14) 1.17 (1.11–1.23)
Rurality Most Urban Ref Ref Ref
Urban 1.04 (1.03–1.06) 1.05 (1.04–1.07) 1.06 (1.02–1.10)
Rural 1.01 (1.00–1.02) 1.07 (1.05–1.08) 1.13 (1.08–1.18)
Most Rural 1.01 (0.97–1.05) 1.12 (1.10–1.15) 1.36 (1.27–1.45)
Age at first ESRD service date 18–39 Ref Ref Ref
40–65 2.05 (2.02–2.09) 2.00 (1.95–2.06) 2.16 (2.03–2.30)
Over 65 4.29 (4.22–4.37) 4.13 (4.01–4.25) 4.43 (4.16–4.71)
aHR (95% CI) = Hazard ratio (95% Confidence Interval).
https://doi.org/10.1371/journal.pone.0214094.t003
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had a median increased survival of 3.4 months. While this observation was unexpected given
the importance of continuous access to care for patients with ESRD, other studies have also
found that living closer to a hospital does not always improve survival [21,27,65] and may lead
to overutilization [19,66]. One possibility for this discrepancy is that people living farther from
a hospital are more likely to utilize primary and specialist care facilities more regularly which
can improve overall health [67,68]. Because we did not include any variables accounting for
care or insurance prior to ESRD development, we could be missing an important contributing
factor related to hospital utilization [19,65]. Future efforts to elucidate the relationship between
access to care and survival time with ESRD should incorporate an additional metric for this
important sociodemographic contribution to survival.
When we analyzed the effect that environmental quality has on survival time for patients
with ESRD using the EQI, we did not find any clear association across EQI strata. However,
when the full model was adjusted for EQI and stratified by distance to the nearest hospital, we
found an association between survival time and the EQI. Patients living within 10 miles of the
nearest hospital had a 6 month increase in median survival time when living in the worst EQI
percentile as compared to the best EQI percentile. This association flipped for patients living
over 20 miles from the nearest hospital with a 9 month increase in median survival time when
living in the best EQI percentile as compared to the worst EQI percentile. This pattern also
holds across different age groups and different rural and urban categories. Interestingly, this
pattern also held for the built and sociodemographic domains of the EQI, suggesting that these
two domains may be contributing to the effect that we observe. One possibility for this unex-
pected pattern is that the EQI inadequately captures these components of the environment
that have the most influence on ESRD survival. Some domains of the EQI are better repre-
sented than others, such as the air domain (87 variables) and the water domain (80 variables).
Table 4. Hazard ratios for ESRD and built and sociodemographic EQI domain stratified by distance to the nearest
hospital (1,092,281 patients, 2000–2013).
Built EQI
Under 10 miles 10–20 miles Over 20 miles
HR (95% CI)a HR (95% CI) HR (95% CI)
EQI Category EQI 0–5% (best) Ref Ref Ref
EQI 5–20% 0.98 (0.87–1.1) 1 (0.95–1.05) 1.08 (0.97–1.21)
EQI 20–40% 0.93 (0.83–1.04) 0.96 (0.91–1.01) 0.97 (0.88–1.07)
EQI 40–60% 0.93 (0.83–1.05) 0.88 (0.84–0.93) 0.97 (0.87–1.07)
EQI 60–80% 0.94 (0.84–1.05) 0.96 (0.91–1.01) 1.08 (0.98–1.19)
EQI 80–95% 0.88 (0.78–0.99) 0.92 (0.87–0.97) 1.08 (0.97–1.2)
EQI 95–100% (worst) 0.92 (0.82–1.04) 0.91 (0.86–0.96) 1.07 (0.96–1.19)
Sociodemographic EQI
Under 10 miles 10–20 miles Over 20 miles
HR (95% CI) HR (95% CI) HR (95% CI)
EQI Category EQI 0–5% (best) Ref Ref Ref
EQI 5–20% 1.05 (1.02–1.08) 1.12 (1.09–1.15) 1.11 (1.06–1.17)
EQI 20–40% 0.93 (0.9–0.95) 1.15 (1.12–1.18) 1.18 (1.12–1.24)
EQI 40–60% 1.04 (1.01–1.06) 1.15 (1.12–1.18) 1.15 (1.1–1.2)
EQI 60–80% 1.02 (0.99–1.05) 1.14 (1.11–1.17) 1.22 (1.17–1.27)
EQI 80–95% 0.99 (0.96–1.02) 1.14 (1.11–1.17) 1.29 (1.2–1.39)
EQI 95–100% (worst) 0.96 (0.93–0.98) 1.12 (1.07–1.17) 1.17 (1.09–1.27)
aHR (95% CI) = Hazard ratio (95% Confidence Interval.
https://doi.org/10.1371/journal.pone.0214094.t004
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However the built domain (14 variables) and sociodemographic domain (12 variables) have
less data owing to fewer sources being available for use [40]. Based on our findings with access
to care, the built domain may be an important influence in survival for patients with ESRD.
Further, because poorer socioeconomic status is a risk factor for ESRD [2,28,29], the sociode-
mographic domain is likely to be important in capturing the environmental influence on
ESRD. The sociodemographic domain has variables related to income and education [41],
both of which have been highlighted as important social factors in kidney disease [5,29]. How-
ever, the generalized measures at the county level of the EQI may not be of sufficient resolution
to capture social gradients that likely influence survival in patients with ESRD. Additionally,
other cultural and behavioral factors at the individual level such as familial support and atti-
tudes towards health [5,8,69] are not captured in this county-level measure of socioeconomic
status.
Another possible contributor to the unclear association between hospital distance, the EQI,
and ESRD survival time is that the environment may not be resolved well at the county level.
The EQI was constructed at the county level as this was the geographic level at which most
data was consistently available [40]. However, county size is varied across the US with the
3,111 counties in our study ranging from 6.3 mi2 in Fairfax City, Virginia to 146,000 mi2 in
Yukon-Koyukuk, Alaska. Larger counties also have an apparent association with better EQIs.
Less than 1% of the counties in our study are over 10,000 mi2, yet 70% of them are located in
the top three EQI percentiles. Further, because individual level behaviors are crucial in deter-
mining neighborhood health, refining the geographic region below the county level may be
more important for diseases where the sociodemographic domain plays a stronger role
[69,70]. While a preliminary comparison of the full model stratified by distance to the nearest
hospital and county size did not change the pattern we found with all counties in one model,
refining the level of analysis to be at a geographic scale finer than the county level may better
elucidate elements of the environment influencing survival.
An advantage of our study is our determination of access to healthcare for a geographic
region. While the EQI does have a variable in the built domain to describe healthcare, the met-
ric is calculated differently than ours and only counties with healthcare-related businesses
include this measure [71]. By determining distance to the nearest hospital regardless of county
lines, we are providing an improved measure of access to care for each county than what is
already contained within the EQI. Further, by determining the distance at the county level
rather than directly from a patient’s address, we are enabling distances to be calculated relative
to a number of different locations within a person’s county (e.g., medical visits may be made
from a place of work rather than a place of residence [47]). Another advantage of our study is
that it focuses only on individuals who remained in one county for the duration of their life-
time. Focusing our study in this way eliminated almost a quarter of the patients we could have
included in our study, however despite small differences in survival time the demographic
makeup of these patients was comparable to those of the patients that remained. Because early
detection of ESRD is expected to delay adverse outcomes [15–17], survival time for ESRD
would depend on the environment and access to care before diagnosis. While an individual
county’s average hospital distance and EQI would be unlikely to remain constant over the
course of an individual’s lifetime, narrowing the study in this manner ensures that all patients
who remained within one county experienced a similar environmental change.
One key assumption of our study is that the average distance to the nearest hospital is an
equally valid metric in both urban and rural regions of the US. While numerous studies have
found the Euclidian distance to be highly correlated with road network distances when assess-
ing access to healthcare [47–53], exception can be made in more rural areas as the geographical
barriers to healthcare may be underestimated [48,52]. Despite this, we still found the same
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associations in both urban and rural counties. Additionally, the hospital data we used were reg-
istered with Medicare, so it is possible that we are missing some other hospitals that would
have been utilized by the individuals in our study.
Another limitation of our study is the variation between the timeframes of data we are
using. The patient data from USRDS covers the years 2000–2013 while the EQI data covers the
years 2000–2005. However, several sources of the data included in the EQI are derived from
census data which are updated every ten years, meaning that multiple elements of the EQI
would remain the same at least through 2010 [40]. We used a 2018 release of hospital data
from the Medicare website [56] which regularly updates hospital information and contains
archived hospital data back to 2005. However, these archived data comprise several addresses
that no longer exist making it difficult to pinpoint even approximate locations for many
hospitals. Despite our hospital dataset being outside the timeframe under study, we find it rep-
resentative as hospital closures and openings occurred within the 2000–2013 timeframe. Com-
paring hospital provider IDs between 2005 and 2013, we found 10% of the hospitals from 2005
missing from the 2013 data and 24% of the hospitals from 2013 data missing from the 2005
data. Comparing the 2013 data to our 2018 hospital data, 8% of the respective hospitals were
missing from the other dataset. Future studies could analyze whether these hospital closures
and openings had any influence on patient survival. Additionally, given the 14 year timeframe
of our study, changes in the treatment of ESRD during that time as well as implementation of
the Affordable Care Act could be important factors to consider when trying to better elucidate
the associations between patient survival and access to healthcare [72].
Conclusions
Both access to care and the broader environment were important factors to consider in sur-
vival for patients with ESRD. The influence of the environment on survival for patients with
ESRD has not been explored in depth before and the additional level of influence related to
access to care emphasizes the importance of considering multiple factors when looking at sur-
vival for diseases with such poor prognoses. Our study found an unexpected association
among hospital distance, the overall environment, and ESRD survival time, and elucidated
that the built and sociodemographic environmental domains may be contributing to this asso-
ciation. Future efforts should explore additional factors related to socioeconomic standing and
analyze influences of the environment at geographic scales smaller than the county level.
Other factors related to access to care such as insurance status prior to diagnosis and use of pri-
mary versus secondary care should also be explored for their influences on ESRD progression.
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